Yields for You Income Strategy A ETF (YFYA)
Live price chart, market sentiment, and community perspectives for Yields for You Income Strategy A ETF (AMEX: YFYA).
Live price chart, market sentiment, and community perspectives for Yields for You Income Strategy A ETF (AMEX: YFYA).
On our desk, we are watching the 1.25% prospectus net expense ratio very closely. For an actively managed fund-of-funds sitting in the US Fund Ultrashort Bond category, a 1.25% fee hurdle is quite steep. Even with a TTM yield of 5.20% and an SEC yield of 4.06%, that fee eats significantly into the net distribution profile, making it a tough sell compared to passive ultra-short alternatives.
Looking at the quantitative assessment from Morningstar, YFYA holds a negative rating under its process pillar. While the fund aims for total return consistent with capital preservation by dynamically shifting between short- and long-term bonds, AAA assets, and preferred stocks, the automated evaluation suggests the execution framework hasn't fully convinced independent fundamental evaluators.
When evaluating the trading liquidity for our risk models, I noted that YFYA's average volume sits around 7,000 to 17,000 shares, though periodic spikes occur. Short interest saw a sharp 51.2% drop in June down to just 1,600 shares, indicating negligible bearish speculation or borrow pressure. With 6 hedge funds and institutions holding roughly $750K to $791K, market float and sentiment remain relatively insulated.
When pitching conservative yield strategies to clients, I emphasize examining the fund-of-funds architecture detailed in Teucrium's prospectus. Because YFYA allocates across various actively managed and index-tracking vehicles, transparency into the exact daily underlying duration risk requires checking the latest SEC filings or contacting U.S. Bank for underlying portfolio disclosures.
From a portfolio construction standpoint, the fund's strategy of utilizing underlying ETFs—some managed by affiliated entities—introduces layered fee structures. Although the turnover is low at 12%, investors need to weigh whether the dynamic rebalancing into investment-grade debt, government bonds, and preferred stock justifies the 1.25% expense ratio against standard benchmark-tracking short duration products.
Explore plasma cleansing, somatic organ swaps, and BCI.